Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine

Journal of Virology

Volumn 87, Issue 6, 2013, Pages 3053-3061

  Rockman, Steven ^a   Brown, Lorena E ^b   Barr, Ian G ^c   Gilbertson, Brad ^b   Lowther, Sue ^d   Kachurin, Anatoly ^e   Kachurina, Olga ^e   Klippel, Jessica ^d   Bodle, Jesse ^d   Pearse, Martin ^a   Middletond, Deborah ^a  

^a CSL LIMITED   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^d CSIRO   (Australia)

^e VaxDesign Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ANTIBODY; IMMUNOLOGICAL ADJUVANT; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NEURAMINIDASE ANTIBODY; SIALIC ACID; TRIPLE VACCINE; UNCLASSIFIED DRUG; VIRUS SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS PROTECTION; DRUG FORMULATION; ENZYME INHIBITION; ENZYME PURIFICATION; FERRET; IMMUNE RESPONSE; INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; LETHAL DOSE; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SEASONAL INFLUENZA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CROSS PROTECTION; FERRETS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INJECTIONS, INTRAMUSCULAR; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; VIRAL PROTEINS;

EID: 84874698540     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02434-12     Document Type: Article

References (32)

1. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420-428.
2. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-1541.
3. Wang X, Zhao J, Tang S, Ye Z, Hewlett I. 2010. Viremia associated with fatal outcomes in ferrets infected with avian H5N1 influenza virus. PLoS One 5:e12099. doi:10.1371/journal.pone.0012099.
4. Govorkova EA, Rehg JE, Krauss S, Yen HL, Guan Y, Peiris M, Nguyen TD, Hanh TH, Puthavathana P, Long HT, Buranathai C, Lim W, Webster RG, Hoffmann E. 2005. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J. Virol. 79:2191-2198.
5. Gao R, Dong L, Dong J, Wen L, Zhang Y, Yu H, Feng Z, Chen M, Tan Y, Mo Z, Liu H, Fan Y, Li K, Li CK, Li D, Yang W, Shu Y. 2010. A systematic molecular pathology study of a laboratory confirmed H5N1 human case. PLoS One 5:e13315. doi:10.1371/journal.pone.0013315.
6. Zhang Z, Zhang J, Huang K, Li KS, Yuen KY, Guan Y, Chen H, Ng WF. 2009. Systemic infection of avian influenza A virus H5N1 subtype in humans. Hum. Pathol. 40:735-739.
7. Hessel L. 2009. Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges. Influenza Other Respir. Viruses 3:165-170.
8. Brown LE, Kelso A. 2009. Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes. Immunol. Cell Biol. 87:300-308.
9. van Maurik A, Sabarth N, Dacho HS, Bruhl P, Schwendinger M, Crowe BA, Noel Barrett P, Kistner O, Keith Howard M. 2010. Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination. Vaccine 28:1778-1785.
10. Ichinohe T, Tamura S, Kawaguchi A, Ninomiya A, Imai M, Itamura S, Odagiri T, Tashiro M, Takahashi H, Sawa H, Mitchell WM, Strayer DR, Carter WA, Chiba J, Kurata T, Sata T, Hasegawa H. 2007. Crossprotection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J. Infect. Dis. 196:1313-1320.
11. Van Reeth K, Braeckmans D, Cox E, Van Borm S, van den Berg T, Goddeeris B, De Vleeschauwer A. 2009. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus. Vaccine 27:6330-6339.
12. Garcia JM, Pepin S, Lagarde N, Ma ES, Vogel FR, Chan KH, Chiu SS, Peiris JS. 2009. Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin. PLoS One 4:e7918. doi:10.1371/journal.pone.0007918.
13. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ. 2007. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med. 4:e59. doi:10.1371/journal.pmed.0040059.
14. Gioia C, Castilletti C, Tempestilli M, Piacentini P, Bordi L, Chiappini R, Agrati C, Squarcione S, Ippolito G, Puro V, Capobianchi MR, Poccia F. 2008. Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg. Infect. Dis. 14:121-128.
15. Qin CF, Qin ED. 2008. Seasonal influenza vaccination may mitigate the potential impact of an H5N1 pandemic. Chin. Med. J. (Engl.). 121:1481-1483.
16. Middleton D, Rockman S, Pearse M, Barr I, Lowther S, Klippel J, Ryan D, Brown L. 2009. Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization. J. Virol. 83:7770-7778.
17. Coulter A, Wong TY, Drane D, Bates J, Macfarlan R, Cox J. 1998. Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines. Vaccine 16:1243-1253.
18. Boyle J, Eastman D, Millar C, Camuglia S, Cox J, Pearse M, Good J, Drane D. 2007. The utility of ISCOMATRIX adjuvant for dose reduction of antigen for vaccines requiring antibody responses. Vaccine 25:2541-2544.
19. Pearse MJ, Drane D. 2005. ISCOMATRIX adjuvant for antigen delivery. Adv. Drug Deliv. Rev. 57:465-474.
20. Lambre CR, Chauvaux S, Pilatte Y. 1989. Fluorometric assay for the measurement of viral neuraminidase in influenza vaccines. Vaccine 7:104-105.
21. Bodle J, Verity EE, Ong C, Vandenberg K, Shaw R, Barr IG, Rockman S. 15 May 2012. Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion. Influenza Other Respir. Viruses [Epub ahead of print.] doi:10.1111/j.1750-2659.2012.00375.x.
22. Drake D, Singh I, Nguyen N, Kachurin A, Wittman V, Parkhill R, Kachurina O, Moser J, Burdin N, Moreau M, Misretta N, Byers A, Dhir V, Tapia T, Vernhes C, Gangur J, Kamala T, Swaminathan N, Warren W. 2012. In vitro biomimetic model of the human immune system for predictive vaccine assessments. Disruptive Sci. Technol. 1:28-40.
23. Aymard-Henry M, Coleman MT, Dowdle WR, Laver WG, Schild GC, Webster RG. 1973. Influenzavirus neuraminidase and neuraminidaseinhibition test procedures. Bull. World Health Organ. 48:199-202.
24. Xie H, Liu TM, Lu X, Wu Z, Belser JA, Katz JM, Tumpey TM, Ye Z. 2009.Alive attenuated H1N1M1mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/ 2004, in mice. J. Infect. Dis. 200:1874-1883.
25. Soundararajan V, Tharakaraman K, Raman R, Raguram S, Shriver Z, Sasisekharan V, Sasisekharan R. 2009. Extrapolating from sequence- the 2009 H1N1 'swine' influenza virus. Nat. Biotechnol. 27:510-513.
26. Dowdle WR, Downie JC, Laver WG. 1974. Inhibition of virus release by antibodies to surface antigens of influenza viruses. J. Virol. 13:269-275.
27. Hashimoto G, Wright PF, Karzon DT. 1983. Antibody-dependent cellmediated cytotoxicity against influenza virus-infected cells. J. Infect. Dis. 148:785-794.
28. Easterbrook JD, Schwartzman LM, Gao J, Kash JC, Morens DM, Couzens L, Wan H, Eichelberger MC, Taubenberger JK. 2012. Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice. Virology 432:39-44.
29. Chen Z, Kim L, Subbarao K, Jin H. 2012. The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets. Vaccine 30:2516-2522.
30. Baz Morelli A, Becher D, Koernig S, Silva A, Drane D, Maraskovsky E. 2012. ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases. J. Med. Microbiol. 61:935-943.
31. Wagner R, Matrosovich M, Klenk HD. 2002. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol. 12:159-166.
32. Johansson BE, Moran TM, Kilbourne ED. 1987. Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenzaAvirus surface glycoproteins. Proc. Natl. Acad. Sci. U. S. A. 84:6869-6873.